Mark A. McPartland

2020

In 2020, Mark A. McPartland earned a total compensation of $480K as Vice President, Corporate Development at Vistagen Therapeutics, a 5% decrease compared to previous year.

Compensation breakdown

Option Awards$179,988
Salary$300,000
Total$479,988

McPartland received $300K in salary, accounting for 63% of the total pay in 2020.

McPartland also received $180K in option awards.

Rankings

In 2020, Mark A. McPartland's compensation ranked 11,139th out of 13,090 executives tracked by ExecPay. In other words, McPartland earned more than 14.9% of executives.

ClassificationRankingPercentile
All
11,139
out of 13,090
15th
Division
Manufacturing
4,764
out of 5,618
15th
Major group
Chemicals And Allied Products
1,977
out of 2,251
12th
Industry group
Drugs
1,729
out of 1,951
11th
Industry
Pharmaceutical Preparations
1,277
out of 1,456
12th
Source: SEC filing on July 27, 2020.

McPartland's colleagues

We found four more compensation records of executives who worked with Mark A. McPartland at Vistagen Therapeutics in 2020.

2020

Shawn Singh

Vistagen Therapeutics

Chief Executive Officer

2020

H Snodgrass

Vistagen Therapeutics

Chief Scientific Officer

2020

Jerrold Dotson

Vistagen Therapeutics

Chief Financial Officer

2020

Mark Smith

Vistagen Therapeutics

Chief Medical Officer

News

You may also like